Applicability of predictive models for 30-day unplanned hospital readmission risk in paediatrics: a systematic review

Ines Marina Niehaus1, Nina Kansy2, Stephanie Stock3

  • 1Department of Business Administration and Health Care Management, University of Cologne, Cologne, Germany niehaus@wiso.uni-koeln.de.

BMJ Open
|March 31, 2022
PubMed

Insights

Multivariable predictive models can identify children at high risk for 30-day unplanned hospital readmissions. Improving reporting completeness is crucial for practical application of these pediatric readmission risk models.

Area of Science:

  • Pediatric healthcare research
  • Clinical prediction modeling
  • Health services research

Background:

  • Unplanned hospital readmissions in children pose a significant burden on healthcare systems.
  • Predictive models are being developed to identify pediatric patients at high risk for readmission.
  • Assessing the performance and reporting quality of these models is essential for their clinical utility.

Purpose of the Study:

  • To systematically review multivariable predictive models for 30-day unplanned hospital readmissions (UHRs) in pediatrics.
  • To describe the performance and reporting completeness of these models.
  • To determine their potential for practical application in clinical settings.

Main Methods:

  • A systematic review of studies published in CINAHL, Embase, and PubMed up to October 2021.
  • Inclusion of English or German studies developing or validating pediatric UHR predictive models.
  • Extraction of study characteristics, significant risk factors, performance measures (e.g., c-statistic), and assessment of reporting quality using TRIPOD criteria.

Main Results:

  • 37 predictive models were identified across 28 studies, with participant numbers ranging from 190 to 1.4 million.
  • Comorbidity and length of stay were the most common significant risk factors.
  • 23 models had a c-statistic > 0.7, indicating good predictive performance, primarily for use at discharge. Median TRIPOD adherence was 59%, with moderate to low study quality noted.

Conclusions:

  • Multivariable predictive models show promise for identifying pediatric patients at elevated risk of readmission.
  • Enhancing the completeness of reporting, especially for implementation-relevant items, is necessary to support the practical application of these models.
  • Further research should focus on improving model transparency and addressing study quality to facilitate clinical integration.
Abstract

Related Concept Videos

Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
644
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
181
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
414
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
186